Delivery Order SPE2DB20D1050-SPE2DB24FH47K
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,602.20 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order from the Defense Logistics Agency (DLA) for Eliquis 5 mg tablets. The contract, valued at $3,536.55, has an ultimate completion date of December 31, 2024 and is a firm fixed-price contract. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of a larger Indefinite Delivery...
- This federal contract award, valued at $91,560.21, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product used for various medical conditions. The contract has a period of performance through February 26, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
- This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Eliquis 5 mg tablets. The $11,388.46 firm fixed price delivery order contract has an ultimate completion date of March 11, 2025. Amerisourcebergen is the prime contractor, and the contract is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,002.81, is for the delivery of Eliquis 5 mg tablets. This contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Eliquis 5 mg tablets. The contract, valued at $17,951.80, is a firm fixed price delivery order with an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $15,003.10, is for the delivery of Eliquis 5 mg tablets. It is a firm-fixed price delivery order contract with an ultimate completion date of December 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,044.40 firm fixed-price delivery order contract, which runs through December 31, 2024, is for the provision of Eliquis 5 mg tablets. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a vehicle...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp (a for-profit corporate office division) for the supply of Eliquis 5 mg tablets. The contract, valued at $59,730.03, is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals...
- This federal contract award, with ID SPE2DX15D2205|SPE2DX24F74DU, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $49,385.92 firm-fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The contract has an ultimate completion date of November 13, 2023 and was awarded on November 9, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB24FH47KDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $11,372.01, is a Firm Fixed Price Delivery Order for the procurement of Eliquis 5 mg tablet 60 count. The contract has an ultimate completion date of January 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies, including military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 1/22/24 |